Cargando…
An Empirical Analysis of the Perceived Challenges and Benefits of Introducing Biosimilars in Bangladesh: A Paradigm Shift
The high demand for and resulting financial success of biopharmaceutical products over the last three decades have seen the door open for close copies of these biological products, also known as biosimilars. This paper seeks to collate all relevant published intelligence with acquired survey data to...
Autores principales: | Kabir, Eva Rahman, Moreino, Shannon Sherwin, Sharif Siam, Mohammad Kawsar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163433/ https://www.ncbi.nlm.nih.gov/pubmed/30189610 http://dx.doi.org/10.3390/biom8030089 |
Ejemplares similares
-
The Breakthrough of Biosimilars: A Twist in the Narrative of Biological Therapy
por: Kabir, Eva Rahman, et al.
Publicado: (2019) -
Molecular Biosimilarity—An AI-Driven Paradigm Shift
por: Niazi, Sarfaraz K.
Publicado: (2022) -
Exploring existing drugs: proposing potential compounds in the treatment of COVID-19
por: Kabir, Eva Rahman, et al.
Publicado: (2021) -
An Efficient Development Paradigm for Biosimilars
por: Webster, Christopher J., et al.
Publicado: (2019) -
Biosimilars entering the clinic without animal studies: A paradigm shift in the European Union
por: van Aerts, Leon AGJM, et al.
Publicado: (2014)